BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8845835)

  • 21. Inactive Atm abrogates DSB repair in mouse cerebellum more than does Atm loss, without causing a neurological phenotype.
    Tal E; Alfo M; Zha S; Barzilai A; De Zeeuw CI; Ziv Y; Shiloh Y
    DNA Repair (Amst); 2018 Dec; 72():10-17. PubMed ID: 30348496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Splice Site Mutation of the ATM Gene Associated with Ataxia Telangiectasia.
    Saeidi K; Saleh Gohari N; Mansouri Nejad SE
    Iran J Child Neurol; 2018; 12(4):111-119. PubMed ID: 30279714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ataxia-Telangiectasia-Mutated Protein Expression as a Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands.
    Bazarsad S; Kim JY; Zhang X; Kim KY; Lee DY; Ryu MH; Kim J
    Yonsei Med J; 2018 Aug; 59(6):717-726. PubMed ID: 29978608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two Novel Mutations Associated With Ataxia-Telangiectasia Identified Using an Ion AmpliSeq Inherited Disease Panel.
    Kuznetsova MV; Trofimov DY; Shubina ES; Kochetkova TO; Karetnikova NA; Barkov IY; Bakharev VA; Gusev OA; Sukhikh GT
    Front Neurol; 2017; 8():570. PubMed ID: 29163336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LC-MS/MS assay for the simultaneous quantitation of the ATM inhibitor AZ31 and the ATR inhibitor AZD6738 in mouse plasma.
    Kiesel BF; Shogan JC; Rachid M; Parise RA; Vendetti FP; Bakkenist CJ; Beumer JH
    J Pharm Biomed Anal; 2017 May; 138():158-165. PubMed ID: 28213176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic ATM but not ATR kinase inhibition abrogates p21-dependent G1 arrest and promotes gastrointestinal syndrome after total body irradiation.
    Vendetti FP; Leibowitz BJ; Barnes J; Schamus S; Kiesel BF; Abberbock S; Conrads T; Clump DA; Cadogan E; O'Connor MJ; Yu J; Beumer JH; Bakkenist CJ
    Sci Rep; 2017 Feb; 7():41892. PubMed ID: 28145510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic consequences of somatic mutations in the ataxia-telangiectasia mutated gene in non-small cell lung cancer.
    Weber AM; Drobnitzky N; Devery AM; Bokobza SM; Adams RA; Maughan TS; Ryan AJ
    Oncotarget; 2016 Sep; 7(38):60807-60822. PubMed ID: 27602502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2).
    Jiang Y; Chen HC; Su X; Thompson PA; Liu X; Do KA; Wierda W; Keating MJ; Plunkett W
    Blood Cancer J; 2016 Sep; 6(9):e465. PubMed ID: 27588518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATM protein is deficient in over 40% of lung adenocarcinomas.
    Villaruz LC; Jones H; Dacic S; Abberbock S; Kurland BF; Stabile LP; Siegfried JM; Conrads TP; Smith NR; O'Connor MJ; Pierce AJ; Bakkenist CJ
    Oncotarget; 2016 Sep; 7(36):57714-57725. PubMed ID: 27259260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.
    Vendetti FP; Lau A; Schamus S; Conrads TP; O'Connor MJ; Bakkenist CJ
    Oncotarget; 2015 Dec; 6(42):44289-305. PubMed ID: 26517239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma : ATM, ATR and FA in lung carcinoma.
    Beumer JH; Fu KY; Anyang BN; Siegfried JM; Bakkenist CJ
    BMC Cancer; 2015 Oct; 15():649. PubMed ID: 26438152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel porcine model of ataxia telangiectasia reproduces neurological features and motor deficits of human disease.
    Beraldi R; Chan CH; Rogers CS; Kovács AD; Meyerholz DK; Trantzas C; Lambertz AM; Darbro BW; Weber KL; White KA; Rheeden RV; Kruer MC; Dacken BA; Wang XJ; Davis BT; Rohret JA; Struzynski JT; Rohret FA; Weimer JM; Pearce DA
    Hum Mol Genet; 2015 Nov; 24(22):6473-84. PubMed ID: 26374845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.
    Campbell A; Krupp B; Bushman J; Noble M; Pröschel C; Mayer-Pröschel M
    Hum Mol Genet; 2015 Nov; 24(22):6331-49. PubMed ID: 26310626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization.
    Bhatia S; Baig NA; Timofeeva O; Pasquale EB; Hirsch K; MacDonald TJ; Dritschilo A; Lee YC; Henkemeyer M; Rood B; Jung M; Wang XJ; Kool M; Rodriguez O; Albanese C; Karam SD
    Oncotarget; 2015 Apr; 6(11):8929-46. PubMed ID: 25879388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twelve novel Atm mutations identified in Chinese ataxia telangiectasia patients.
    Huang Y; Yang L; Wang J; Yang F; Xiao Y; Xia R; Yuan X; Yan M
    Neuromolecular Med; 2013 Sep; 15(3):536-40. PubMed ID: 23807571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 and translation attenuation regulate distinct cell cycle checkpoints during endoplasmic reticulum (ER) stress.
    Thomas SE; Malzer E; Ordóñez A; Dalton LE; van T Wout EFA; Liniker E; Crowther DC; Lomas DA; Marciniak SJ
    J Biol Chem; 2013 Mar; 288(11):7606-7617. PubMed ID: 23341460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular defects in Moroccan patients with ataxia-telangiectasia.
    Jeddane L; Ailal F; Dubois-d'Enghien C; Abidi O; Benhsaien I; Kili A; Chaouki S; Kriouile Y; El Hafidi N; Fadil H; Abilkassem R; Rada N; Bousfiha AA; Barakat A; Stoppa-Lyonnet D; Bellaoui H
    Neuromolecular Med; 2013 Jun; 15(2):288-94. PubMed ID: 23322442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Smad proteins localize to IR-induced double-strand breaks: interplay between TGFβ and ATM pathways.
    Wang M; Saha J; Hada M; Anderson JA; Pluth JM; O'Neill P; Cucinotta FA
    Nucleic Acids Res; 2013 Jan; 41(2):933-42. PubMed ID: 23221633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinase-dead ATM protein causes genomic instability and early embryonic lethality in mice.
    Yamamoto K; Wang Y; Jiang W; Liu X; Dubois RL; Lin CS; Ludwig T; Bakkenist CJ; Zha S
    J Cell Biol; 2012 Aug; 198(3):305-13. PubMed ID: 22869596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of ATM kinase activity leads to embryonic lethality in mice.
    Daniel JA; Pellegrini M; Lee BS; Guo Z; Filsuf D; Belkina NV; You Z; Paull TT; Sleckman BP; Feigenbaum L; Nussenzweig A
    J Cell Biol; 2012 Aug; 198(3):295-304. PubMed ID: 22869595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.